GP efforts to cut antibiotic use failed to curb spread of drug resistant E coli, evaluation finds
BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1953 (Published 05 August 2021) Cite this as: BMJ 2021;374:n1953- Gareth Iacobucci
- The BMJ
Researchers have called for a more radical, multisectoral approach to halting the rise in drug resistant Escherichia coli infections in England after finding that incentivising general practices to reduce antibiotic prescribing on its own was insufficient.
The team from Imperial College London assessed the effects on antimicrobial resistance of NHS England’s “quality premium” scheme, which was introduced in 2015 to reward groups of GPs for reducing inappropriate antibiotic prescribing in primary care, where 70% of antibiotics in England are prescribed.
Their findings, published in the Lancet Infectious Diseases,1 show that while the intervention did reduce antibiotic prescribing, …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.